P3 Health Partners PIII will release its quarterly earnings report on Thursday, 2025-03-27. Here’s a brief overview for investors ahead of the announcement.
Analysts anticipate P3 Health Partners to report an earnings per share (EPS) of $-0.17.
The market awaits P3 Health Partners’s announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.
It’s important for new investors to understand that guidance can be a significant driver of stock prices.
Performance in Previous Earnings
During the last quarter, the company reported an EPS missed by $0.27, leading to a 35.99% drop in the share price on the subsequent day.
Here’s a look at P3 Health Partners’s past performance and the resulting price change:
| Quarter | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|
| EPS Estimate | -0.04 | -0.05 | -0.11 | -0.11 |
| EPS Actual | -0.31 | -0.15 | -0.16 | -0.22 |
| Price Change % | -36.0% | -4.0% | -2.0% | 1.0% |
P3 Health Partners Share Price Analysis
Shares of P3 Health Partners were trading at $0.1829 as of March 25. Over the last 52-week period, shares are down 82.58%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release.
To track all earnings releases for P3 Health Partners visit their earnings calendar on our site.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
Momentum3.97
Growth–
Quality–
Value38.46
Market News and Data brought to you by Benzinga APIs
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
